Fig. 1.

Fig. 2.

Fig. 3.

Fig. 4.

Cellular indicators of non-specific immunity of pikeperch after chloramine T exposure
| Group | Day | |||||
|---|---|---|---|---|---|---|
| 1 | 8 | 15 | 22 | 29 | ||
| SI ± SD | SI ± SD | SI ± SD | SI ± SD | SI ± SD | ||
| RBA (SI) | C | 1.446 ± 0.32 | 1.115 ± 0.33 | 1.002 ± 0.06a | 1.042 ± 0.09 | 1.079 ± 0.23 |
| CLT1 | 1.203 ± 0.14 | 1.072 ± 0.09 | 1.038 ± 0.12a | 1.072 ± 0.29 | 1.131 ± 0.36 | |
| CLT3 | 1.534 ± 0.40 | 1.107 ± 0.39 | 0.773 ± 0.15b | 1.043 ± 0.18 | 1.317 ± 0.20 | |
| PKA (SI) | C | 1.027 ± 0.03 | 0.818 ± 0.22 | 0.860 ± 0.07a | 1.411 ± 0.41a | 0.719 ± 0.10a |
| CLT1 | 0.867 ± 0.07 | 1.103 ± 0.34 | 0.741 ± 0.14ab | 1.159 ± 0.23ab | 0.803 ± 0.21ab | |
| CLT3 | 0.942 ± 0.31 | 0.875 ± 0.33 | 0.631 ± 0.10b | 0.798 ± 0.15b | 0.963 ± 0.12b | |
| MTT ConA (SI) | C | 0.799 ± 0.09 | 0.596 ± 0.05a | 0.754 ± 0.10a | 0.642 ± 0.06a | 0.930 ± 0.24 |
| CLT1 | 0.664 ± 0.03 | 0.818 ± 0.09ab | 0.804 ± 0.06a | 1.925 ± 0.38b | 1.000 ± 0.54 | |
| CLT3 | 0.773 ± 0.13 | 1.097 ± 0.22b | 1.744 ± 0.38b | 1.461 ± 0.18b | 0.577 ± 0.61 | |
| MTT LPS (SI) | C | 1.069 ± 0.04 | 0.970 ± 0.09a | 0.668 ± 0.16a | 0.790 ± 0.19a | 1.127 ± 0.11 |
| CLT1 | 1.000 ± 0.11 | 1.099 ± 0.09ab | 0.932 ± 0.06a | 1.374 ± 0.46b | 1.280 ± 0.34 | |
| CLT3 | 1.033 ± 0.09 | 1.192 ± 0.12b | 1.583 ± 0.59b | 1.153 ± 0.17ab | 1.149 ± 0.35 | |
Humoral indicators of non-specific immunity of pikeperch after chloramine T exposure
| Group | Day | |||||
|---|---|---|---|---|---|---|
| 1 | 8 | 15 | 22 | 29 | ||
| Mean ± SD | Mean ± SD | Mean ± SD | Mean ± SD | Mean ± SD | ||
| LSM (mg L−1) | C | 65.63 ± 4.22a | 69.58 ± 7.67 | 76.56 ± 5.61 | 73.75 ± 11.35a | 77.92 ± 3.16 |
| CLT1 | 101.65 ± 6.87b | 63.34 ± 11.90 | 75.33 ± 14.59 | 112.51 ± 4.02b | 76.41 ± 4.87 | |
| CLT3 | 94.76 ± 17.79b | 64.61 ± 10.64 | 78.91 ± 5.16 | 84.87 ± 4.38a | 72.95 ± 4.81 | |
| CP (IU) | C | 57.06 ± 5.39 | 48.05 ± 3.48 | 51.43 ± 4.79 | 42.59 ± 3.72 | 57.06 ± 5.39 |
| CLT1 | 61.79 ± 5.82 | 47.59 ± 4.68 | 51.99 ± 5.92 | 45.87 ± 2.87 | 61.97 ± 5.82 | |
| CLT3 | 60.49 ± 6.89 | 52.03 ± 9.32 | 55.25 ± 4.88 | 46.74 ± 2.72 | 60.49 ± 6.89 | |
| T-P (g L−1) | C | 43.56 ± 6.15 | 47.19 ± 5.87 | 53.36 ± 25.07 | 47.34 ± 12.66 | 43.56 ± 6.15 |
| CLT1 | 57.79 ± 18.11 | 41.47 ± 5.91 | 76.49 ± 43.85 | 51.57 ± 19.44 | 57.79 ± 18.11 | |
| CLT3 | 59.35 ± 13.21 | 51.99 ± 8.61 | 64.45 ± 28.35 | 59.31 ± 14.69 | 59.35 ± 13.21 | |
| γ-G (g L−1) | C | 7.21 ± 2.06 | 13.46 ± 1.41 | 14.63 ± 2.98 | 15.23 ± 1.93 | 12.05 ± 3.77 |
| CLT1 | 8.80 ± 0.65 | 13.72 ± 2.52 | 17.35 ± 2.70 | 12.96 ± 4.32 | 9.63 ± 1.72 | |
| CLT3 | 9.32 ± 2.21 | 10.69 ± 2.38 | 16.24 ± 1.72 | 17.16 ± 2.19 | 12.95 ± 2.08 | |